|
Mr. Reinhard is a co-founder of Cardium and has served as a director and the Chief Executive Officer President and Treasurer of Cardium since its inception in December 2003. Mr. Reinhard has also served as a director and the Chief Executive Officer and Treasurer of InnerCool Therapies Inc. since March 2006 and as a director and the Chief Executive Officer and President of Tissue Repair Company since August 2006 each a wholly-owned subsidiary of Cardium. Previously he served as a director and the Chief Executive Officer President and Treasurer of Aries Ventures Inc. from October 20 2005 through its merger with Cardium in January 2006. He also served as Chief Financial Officer of Aries Ventures Inc. from October 20 2005 to November 16 2005. For the past ten years Mr. Reinhard has focused on the commercial development of cardiovascular growth factor therapeutics. Before founding Cardium he was a co-founder of Collateral Therapeutics Inc. and served as a director (from 1995) and President (from 1999) of Collateral until the completion of its acquisition by Schering AG Group Germany (Schering) in 2002. He continued as Chief Executive of Collateral through December 2004. Mr. Reinhard played a major role in effecting Collateral’s initial public offering led by Bear Stearns & Co. in 1998 and the sale of Collateral to Schering. Mr. Reinhard has also been Executive Chairman (since 2004) of Artes Medical Inc. a publicly-traded medical technology company. Previously Mr. Reinhard was Vice President and Managing Director of the Henley Group a publicly-traded diversified industrial and manufacturing group and Vice President of various public and private companies created by the Henley Group through spin-out transactions including Fisher Scientific Group a leading international distributor of laboratory equipment and test apparatus for the scientific community Instrumentation Laboratory and IMED Corporation a medical device company. Mr. Reinhard received a B.S. in Finance and an M.B.A. from Babson College. | 